Lupus low disease activity state as a treatment endpoint for systemic lupus erythematosus: a prospective validation study

• Main Authors: Vera Golder, Rangi Kandane-Rathnayake, Molla Huq, Hieu T. Nim, Worawit Louthrenoo, Shue Fen Luo, Yeong Jian Jan Wu, Aisha Lateef, Sargunan Sockalingam, Sandra V. Navarra, Leonid Zamora, Laniyati Hamijoyo, Yasuhiro Katsumata, Masayoshi Harigai, Madelynn Chan, Sean O'Neill, Fiona Goldblatt, Chak Sing Lau, Zhan Guo Li, Alberta Hoi, Mandana Nikpour, Eric F. Morand
• Format: Journal
• Published: 2020
• Subjects: Immunology and Microbiology; Medicine
• Online Access: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85074043891&origin=inward; http://cmuir.cmu.ac.th/jspui/handle/6653943832/67871
• Institution: Chiang Mai University

© 2019 Elsevier Ltd Background: Treat-to-target strategies have improved outcomes in single-organ diseases with simple clinical or laboratory endpoints. A lack of validated endpoints has prevented adoption of treat to target for complex multiorgan conditions, such as systemic lupus erythematosus (SL...